Log in

NASDAQ:CASICASI Pharmaceuticals Earnings Date, Estimates & History

$2.67
+0.05 (+1.91 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.63
Now: $2.67
$2.77
50-Day Range
$1.66
MA: $2.06
$2.77
52-Week Range
$1.15
Now: $2.67
$3.82
Volume150,236 shs
Average Volume316,725 shs
Market Capitalization$269.46 million
P/E RatioN/A
Dividend YieldN/A
Beta0.95

Earnings

CASI Pharmaceuticals (NASDAQ:CASI) Earnings Information

CASI Pharmaceuticals last announced its earnings data on May 11th, 2020. The biotechnology company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.02. The business earned $3.41 million during the quarter, compared to the consensus estimate of $0.79 million. CASI Pharmaceuticals has generated ($0.42) earnings per share over the last year. CASI Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 14th, 2020 based off prior year's report dates.

CASI Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CASI Pharmaceuticals (NASDAQ:CASI) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.3 EPS
Next Year EPS Consensus Estimate: $-0.31 EPS

CASI Pharmaceuticals (NASDAQ CASI) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/14/2020
(Estimated)
       
5/11/20203/31/2020($0.11)($0.09)($0.09)$0.79 million$3.41 millionN/A
3/16/202012/31/2019($0.11)($0.12)($0.13)$1.16 million$1.34 millionN/A
11/12/2019Q3 2019($0.11)($0.10)($0.10)$0.70 million$2.79 millionN/A
8/9/2019Q2 2019($0.09)($0.10)($0.04)N/A
5/15/20193/31/2019($0.09)($0.09)($0.09)$0.62 millionN/A
3/29/201912/31/2018($0.08)($0.10)($0.10)N/A
11/14/2018Q3 2018($0.04)($0.10)($0.10)N/A
8/14/2018Q2 2018($0.07)($0.07)($0.07)N/A
5/15/20183/31/2018($0.07)($0.05)($0.05)N/A
3/29/2018Q4($0.02)($0.08)($0.08)$0.50 millionN/A
11/14/2017Q3 2017($0.04)($0.03)($0.03)N/A
8/14/2017Q2 2017($0.03)($0.04)($0.04)N/A
5/15/2017Q1 2017($0.04)($0.0280)($0.03)N/A
3/31/2017Q4 2016($0.07)($0.05)($0.05)$0.50 millionN/A
11/14/2016Q3 2016($0.08)($0.03)($0.03)N/A
8/15/2016Q2($0.04)($0.08)($0.08)N/A
5/13/2016Q1($0.05)($0.04)($0.04)N/A
3/28/2016Q415($0.03)($0.05)($0.05)$0.03 millionN/A
11/13/2015Q315($0.0650)($0.05)($0.05)$0.10 millionN/A
8/14/2015Q215($0.0550)($0.06)($0.06)$0.27 million$0.02 millionN/A
5/15/2015Q1 2015($0.06)($0.06)$0.02 millionN/A
3/27/2015Q4 2014($0.05)($0.05)$0.02 millionN/A
11/14/2014Q314($0.07)$0.63Listen
8/14/2014Q214($0.06)($0.06)N/A
5/15/2014Q114($0.05)($0.05)($0.05)N/A
3/21/2014Q4 2013($0.05)($0.05)$0.67 millionN/A
11/14/2013Q3 2013($0.05)($0.05)N/A
8/14/2013Q2 2013($0.07)($0.07)N/A
5/15/2013Q1 2013($0.05)($0.05)N/A
3/21/2013Q4 2012($0.02)$1.93 million$0.67 millionN/A
11/14/2012Q312($0.05)N/A
8/14/2012Q2 2012($0.55)($0.55)N/A
5/15/2012Q1 2012($0.23)($0.23)N/A
3/9/2012Q4 2011$0.06$0.06N/A
11/14/2011Q3 2011($0.13)($0.13)N/A
8/15/2011Q2 2011($0.17)($0.17)N/A
5/16/2011Q1 2011($0.25)($0.25)N/A
3/30/2011Q4 2010$0.07$0.07N/A
11/12/2010Q3 2010($0.24)($0.24)N/A
8/16/2010Q2 2010($0.26)$0.10N/A
5/18/2010Q1 2010($0.25)($0.25)N/A
3/29/2010Q4 2009($0.29)($0.29)N/A
11/16/2009Q3 2009$0.01$0.01N/A
8/6/2009Q2 2009($0.40)($0.40)N/A
5/6/2009Q1 2009($0.44)($0.44)N/A
3/12/2009Q4 2008($0.35)($0.35)N/A
11/6/2008Q3 2008($0.43)($0.43)N/A
8/6/2008Q2 2008($0.98)($0.73)N/A
5/2/2008Q1 2008($1.08)($1.08)N/A
3/6/2008Q4 2007($0.53)($0.53)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.